1. Home
  2. CBZ vs ANIP Comparison

CBZ vs ANIP Comparison

Compare CBZ & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBIZ Inc.

CBZ

CBIZ Inc.

HOLD

Current Price

$54.50

Market Cap

2.3B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$77.74

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBZ
ANIP
Founded
1987
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
CBZ
ANIP
Price
$54.50
$77.74
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$41.33
$110.00
AVG Volume (30 Days)
1.8M
256.0K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
134.62
419.23
EPS
2.83
2.32
Revenue
$922,003,000.00
$206,547,000.00
Revenue This Year
$3.92
$21.01
Revenue Next Year
$4.12
$17.59
P/E Ratio
$19.25
$64.55
Revenue Growth
7.79
2.47
52 Week Low
$24.29
$70.15
52 Week High
$67.24
$99.50

Technical Indicators

Market Signals
Indicator
CBZ
ANIP
Relative Strength Index (RSI) 81.19 56.20
Support Level $50.29 $76.87
Resistance Level $55.39 $83.45
Average True Range (ATR) 1.02 2.18
MACD 0.80 0.24
Stochastic Oscillator 93.34 91.45

Price Performance

Historical Comparison
CBZ
ANIP

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: